MAGLi 432 is a non-covalent, potent, highly selective, and reversible MAGL inhibitor. MAGLi 432 binds with high affinity to the MAGL active site, with IC50 values of 4.2 nM (human enzyme) and 3.1 nM (mouse enzyme). MAGLi 432 can be used in the research of chronic inflammation, blood-brain barrier dysfunction, neurological disorders such as multiple sclerosis, Alzheimers disease and Parkinsons disease[1].
Molekulargewicht:
463.80
CAS Nummer:
[2361575-20-2]
Formel:
C22H24BrClN2O2
Target-Kategorie:
MAGL
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
